Trotana - About the company
Trotana is a funded company based in San Diego (United States), founded in 2019 by Gene Yeo and Frank Furnari. It operates as a R&D company manufacturing drugs discovery for multiple therapeutic areas. The company has 1965 active competitors, including 102 funded and 207 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.
Key Metrics
Founded Year
2019
Location
San Diego, United States
Stage
Funding Raised
Investors
Ranked
289th among 1965 active competitors
Employee Count
16 as on Aug 31, 2026
Sign up to download Trotana's company profile
Trotana's funding and investors
Trotana is a funded company. Trotana has 2 institutional investors.
View details of Trotana's funding rounds and investors
Trotana's founders and board of directors
Founder? Claim ProfileThe founders of Trotana are Gene Yeo and Frank Furnari.
Here are the details of Trotana's key team members:
- Gene Yeo: Co-founder of Trotana. Contact Info: 1 email address
- Frank Furnari: Co-Founder of Trotana. Contact Info: 1 email address
View details of Trotana's Founder profiles and Board Members
Trotana's employee count trend
Trotana has 16 employees as of Aug 26. Here is Trotana's employee count trend over the years:
Uncover Trotana's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Trotana's Competitors and alternates
Top competitors of Trotana include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Trotana, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 83/100 | |
2nd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 81/100 | |
3rd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 79/100 | |
4th |  AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 76/100 | |
5th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
6th |  Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 75/100 | |
7th |  Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 71/100 | |
8th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
9th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
10th | Genentech 1976, San Francisco (United States), Acquired | R&D company focused on manufacturing drugs for multiple therapeutic areas | $72.5M | 68/100 | |
289th |  Trotana 2019, San Diego (United States), Funding Raised | R&D company manufacturing drugs discovery for multiple therapeutic areas | - | 29/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Trotana's competitors? Click here to see the top ones
Trotana's Investments and acquisitions
Trotana has made no investments or acquisitions yet.
Reports related to Trotana
Here is the latest report on Trotana's sector:
Are you a Founder ?
FAQs about Trotana
Explore our recently published companies
- Halmblog Music - Accra based, 2022 founded, Unfunded company
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company
- eomii - Unfunded company
- HOLTWORK - Unfunded company
